 This is an open label, randomized investigation of a proprietary blend of amino acids, called Enterade, and its effect on irregularity diarrhea caused by radiation therapy andor chemotherapy including TKI. Subjects will be randomized to receive Enterade or continue standard of care. Two patients will be enrolled on the treatment arm for each patient on the control arm. 